SLABÝ, Ondřej, Roman HRSTKA, Lenka DUBSKÁ, Marek SVOBODA, Eva RŮČKOVÁ, Jaroslava OVESNÁ a Rostislav VYZULA. Significance of microRNA-21 in colorectal cancer pathogenesis. In FEBS Journal. 2008, 275, Suppl. 1. Oxford, UK: FEBS. s. 465-465. ISSN 1742-464X. 2008.
Další formáty:   BibTeX LaTeX RIS
Základní údaje
Originální název Significance of microRNA-21 in colorectal cancer pathogenesis.
Název česky Significance of microRNA-21 in colorectal cancer pathogenesis.
Autoři SLABÝ, Ondřej (203 Česká republika, garant), Roman HRSTKA (203 Česká republika), Lenka DUBSKÁ (203 Česká republika), Marek SVOBODA (203 Česká republika), Eva RŮČKOVÁ (203 Česká republika), Jaroslava OVESNÁ (203 Česká republika) a Rostislav VYZULA (203 Česká republika).
Vydání 2008, 275, Suppl. 1. Oxford, UK, FEBS Journal, od s. 465-465, 1 s. 2008.
Nakladatel FEBS
Další údaje
Originální jazyk angličtina
Typ výsledku Stať ve sborníku
Obor 30200 3.2 Clinical medicine
Stát vydavatele Řecko
Utajení není předmětem státního či obchodního tajemství
Impakt faktor Impact factor: 3.139
Kód RIV RIV/00216224:14110/08:00028239
Organizační jednotka Lékařská fakulta
ISSN 1742-464X
UT WoS 000256633301661
Klíčová slova anglicky colorectal; microRNAs
Štítky colorectal, microRNAs
Příznaky Mezinárodní význam, Recenzováno
Změnil Změnil: prof. RNDr. Ondřej Slabý, Ph.D., učo 42891. Změněno: 30. 9. 2008 09:03.
Anotace
MicroRNAs (miRNAs) are endogenously expressed short non-coding RNAs, that repress protein translation through binding to target mRNAs. Although the number of verified human miRNA is still expanding, only few have been functionally described. However, emerging evidences suggest the involvement of altered regulation of miRNA in pathogenesis of cancers and these genes are thought to function as both tumours suppressor and oncogenes. Previous studies, mainly based on microarrays technology applied on colorectal cancer cell lines, showed altered expression levels of several miRNAs in colorectal cancer (CRC). In our study, we examined by Real-Time PCR expression levels of microRNA-21 (miR-21) in tumors of 29 colorectal cancer patients. For 6 cases of CRC samples also adjacent non-tumor tissues were analyzed. For data normalization we tried different approaches (18S rRNA, GAPDH, let-7a-1). Finally, variability of let-7a-1 expression was shown to be the lowest. Expression levels of miR-21 were significantly higher in tumors comparing to normal mucosa (p = 0,0001). High expression of miR-21 was also associated with lymph node positivity (p = 0,025) and the development of distant metastases (p = 0,009) in CRC patients. To elucidate function of miR-21 in colon cancer cells (DLD1, SW837, HCT116) we tested effects of synthetic 2'OMe-anti-sense-miR-21 (anti-miR-21) transfection (2'OMe-EGFP as control) on their proliferation, cell cycle regulation, sensitization to chemotherapeutic agents (5-fluorouracil, irinotecan, oxaliplatin) and invasive properties. We observed 15-30% decrease of cells proliferation by MTT test after transfection of anti-miR-21 in comparison with control cells. Moreover, cytostatic effect of treatments was enhanced about 20-30% in transfected colon cancer cells. Interestingly, these actions of anti-miR-21 were not associated with significant changes of cell cycle. We hypothesize, that miR-21 affects directly proliferation and now we are testing common markers of proliferation (Ki-67) and those which are possibly under miR-21 post-transcriptional control. Simultaneously, we evaluate changes in invasive properties of anti-miR-21 transfected cancer cells by matrigel invasion assay. Our results suggest possible role of miR-21 in colorectal cancer pathogenesis. Supported by IGA MZ CR NR/9076-4 and project MZ0MOU2005
Anotace česky
MicroRNAs (miRNAs) are endogenously expressed short non-coding RNAs, that repress protein translation through binding to target mRNAs. Although the number of verified human miRNA is still expanding, only few have been functionally described. However, emerging evidences suggest the involvement of altered regulation of miRNA in pathogenesis of cancers and these genes are thought to function as both tumours suppressor and oncogenes. Previous studies, mainly based on microarrays technology applied on colorectal cancer cell lines, showed altered expression levels of several miRNAs in colorectal cancer (CRC). In our study, we examined by Real-Time PCR expression levels of microRNA-21 (miR-21) in tumors of 29 colorectal cancer patients. For 6 cases of CRC samples also adjacent non-tumor tissues were analyzed. For data normalization we tried different approaches (18S rRNA, GAPDH, let-7a-1). Finally, variability of let-7a-1 expression was shown to be the lowest. Expression levels of miR-21 were significantly higher in tumors comparing to normal mucosa (p = 0,0001). High expression of miR-21 was also associated with lymph node positivity (p = 0,025) and the development of distant metastases (p = 0,009) in CRC patients. To elucidate function of miR-21 in colon cancer cells (DLD1, SW837, HCT116) we tested effects of synthetic 2'OMe-anti-sense-miR-21 (anti-miR-21) transfection (2'OMe-EGFP as control) on their proliferation, cell cycle regulation, sensitization to chemotherapeutic agents (5-fluorouracil, irinotecan, oxaliplatin) and invasive properties. We observed 15-30% decrease of cells proliferation by MTT test after transfection of anti-miR-21 in comparison with control cells. Moreover, cytostatic effect of treatments was enhanced about 20-30% in transfected colon cancer cells. Interestingly, these actions of anti-miR-21 were not associated with significant changes of cell cycle. We hypothesize, that miR-21 affects directly proliferation and now we are testing common markers of proliferation (Ki-67) and those which are possibly under miR-21 post-transcriptional control. Simultaneously, we evaluate changes in invasive properties of anti-miR-21 transfected cancer cells by matrigel invasion assay. Our results suggest possible role of miR-21 in colorectal cancer pathogenesis. Supported by IGA MZ CR NR/9076-4 and project MZ0MOU2005
Návaznosti
NR9076, projekt VaVNázev: Genomické profilování v predikci odpovědi na chemoradioterapii u pacientů s lokálně pokročilým karcinomem konečníku
VytisknoutZobrazeno: 20. 4. 2024 08:24